BHEIX
Price
$28.41
Change
+$0.15 (+0.53%)
Updated
Jan 17 closing price
Net Assets
1.92B
ENHRX
Price
$10.48
Change
+$0.07 (+0.67%)
Updated
Jan 17 closing price
Net Assets
156.71M
Ad is loading...

BHEIX vs ENHRX

Header iconBHEIX vs ENHRX Comparison
Open Charts BHEIX vs ENHRXBanner chart's image
BlackRock High Equity Income K
Price$28.41
Change+$0.15 (+0.53%)
VolumeN/A
Net Assets1.92B
Cullen Enhanced Equity Income Retail
Price$10.48
Change+$0.07 (+0.67%)
VolumeN/A
Net Assets156.71M
BHEIX vs ENHRX Comparison Chart
Loading...
View a ticker or compare two or three
VS
BHEIX vs. ENHRX commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BHEIX is a StrongBuy and ENHRX is a StrongBuy.

Ad is loading...
FUNDAMENTALS
Fundamentals
BHEIX has more cash in the bank: 1.92B vs. ENHRX (157M). BHEIX pays higher dividends than ENHRX: BHEIX (6.55) vs ENHRX (5.91). BHEIX was incepted earlier than ENHRX: BHEIX (5 years) vs ENHRX (9 years). ENHRX is a more actively managed with annual turnover of: 176.00 vs. BHEIX (126.00). ENHRX has a lower initial minimum investment than BHEIX: ENHRX (1000) vs BHEIX (5000000). ENHRX (11.28) and BHEIX (11.27) have marching annual gain over last year.
BHEIXENHRXBHEIX / ENHRX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence5 years9 years-
Gain YTD1.2903.04842%
Front LoadN/AN/A-
Min. Initial Investment50000001000500,000%
Min. Initial Investment IRAN/AN/A-
Net Assets1.92B157M1,224%
Annual Yield % from dividends6.555.91111%
Returns for 1 year11.2711.28100%
Returns for 3 years14.718.46174%
Returns for 5 yearsN/A31.71-
Returns for 10 yearsN/AN/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TROO1.910.23
+13.69%
TROOPS
CNA48.860.10
+0.21%
CNA Financial Corp
LXP8.15-0.05
-0.61%
LXP Industrial Trust
OBE5.63-0.05
-0.88%
Obsidian Energy Ltd
CNSP0.10-0.01
-6.34%
CNS Pharmaceuticals Inc